New trends in macromolecular X-ray crystallography

Current Opinion in Chemical Biology

Volumn 1, Issue 3, 1997, Pages 365-369

  Wery, Jean Pierre ^a   Schevitz, Richard W ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN;

CHEMISTRY; METHODOLOGY; PROTEIN CONFORMATION; REVIEW; X RAY CRYSTALLOGRAPHY;

CRYSTALLOGRAPHY, X-RAY; PROTEIN CONFORMATION; PROTEINS;

EID: 0031244199     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1367-5931(97)80075-0     Document Type: Article

References (43)

1. Kendrew JC: Myoglobin and the structure of proteins. Science 1963, 139:1259-1266.
2. Deeks SG, Smith M, Holodniy M, Kahn JO: HIV-1 protease inhibitors. A review for clinicians. JAMA 1997, 277:145-153.
3. Tsukihara T, Aoyama H, Yamashita E, Tomizaki T, Yamaguchi H, Shinzawa-Itoh K, Nakashima R, Yaono R, Yoshikawa S: The whole structure of the 13-subunit oxidized cytochrome c oxidase at 2.8 Å. Science 1996, 272:1136-1144.
4. Gennis R, Ferguson-Miller S: Structure of cytochrome c oxidase, energy generator of aerobic life. Science 1995, 269:1063-1064.
5. Tsukihara T, Aoyama H, Yamashita E, Tomizaki T, Yamaguchi H, Shinzawa-Itoh K, Nakashima R, Yaono R, Yoshikawa S: Structures of metal sites of oxidized bovine heart cytochrome c oxidase at 2.8 Å. Science 1995, 269:1069-1074.
6. Ferré-D'Amaré, Adrian R, Burley SK: Dynamic light scattering in evaluating crystallizability of macromolecules. Methods Enzymol 1997, 276:157-166. This is an excellent review of the use of dynamic light scattering and its application to macromolecular crystallization.
7. Bernstein BE, Michels PAM, Hol WGJ: Synergistic effects of substrate-induced conformational changes in phosphoglycerate kinase activation. Nature 1997, 385:275-278.
8. Zhang F, Basinski MB, Beals JM, Briggs SL, Churgay LM, Clawson DK, DiMarchi RD, Furman TC, Hale JE, Hsiung HM et al.: Crystal structure of the obese protein leptin-E100. Nature 1997, 387:206-209.
9. Cohen SL: Domain elucidation by mass spectrometry. Structure 1996, 4:1013-1016.
10. Garcia KC, Degano M, Stanfield RL, Brunmark A, Jackson MR, Peterson PA, Teyton L, Wilson IA: A T-cell receptor structure at 2.5 Å and its orientation in the TCR-MHC complex. Science 1996, 274:209-219. Crystals of T-cell receptor-MHC peptide complex were obtained by successive digestion of the 10-15 carboxy-terminal residues by carboxypeptidases A and B. Truncating the carboxyl terminus was apparently more important than perfect homogeneity of the cut.
11. Xie X, Kokubo T, Cohen SL, Mirza UA, Hoffmann A, Chait BT, Roeder RG, Nakatani Y, Burley SK: Structural similarity between TAFs and the heterotetrameric core of the histone octamer. Nature 1996, 380:316-322.
12. Xu W, Harrison SC, Eck MJ: Three-dimensional structure of the tyrosine kinase c-Src. Nature 1997, 385:595-601. Human c-Src tyrosine kinase is a Src-family protein. Its structure was determined from crystals grown from a deletion mutant in which its amino-terminal domain, containing the membrane-anchoring region and a unique nonconserved region, was omitted. The retained regions included the Src homology (SH) domains SH3, SH2, and catalytic SH1 domains plus the short carboxy-terminal tail containing the critical regulatory tyrosine. This structure and the following tyrosine kinase Hck (Sicheri et al. (1997); [13•]) give us a basis for understanding how these eukaryotic signal transducers are activated and deactivated via phosphorylation of the carboxy-terminal tyrosine.
13. Sicheri F, Moarefi I, Kuriyan J: Crystal structure of the Src family tyrosine kinase Hck. Nature 1997, 385:602-609. Tyrosine kinase Hck is a Src-family protein. A similar approach to c-Src tyrosine kinase (see also Xu et al. (1997); [12•]) was used to obtain crystals in which the amino-terminal domain, containing the membrane anchoring regions and unique nonconserved regions, was omitted. Like c-Src tyrosine kinase, tyrosine kinase Hck also retained the SH3, SH2 and catalytic domains plus the short carboxy-terminal tail containing the critical regulatory tyrosine.
14. Scheffzek K, Lautwein A, Kabsch W, Ahmadian MR, Wittinghofer A: Crystal structure of the GTPase-activating domain of human p120GAP and implications for the interaction with Ras. Nature 1996, 384:591-596. The Ras-specific GTPase-activating protein (GAP) is a very large protein (120 kDa) containing several signaling domains; its crystal structure was recently determined from a 334 residue, catalytically active carboxy-terminal fragment which contains all of the conserved residues. This has given us a model for GAP interaction with Ras, which has been implicated in about 30% of all human tumors.
15. Geiger JH, Hahn S, Lee S, Sigler PB: Crystal structure of the yeast TFIIA/TBP/DNA complex. Science 1996, 272:830-836. The structure determination of this promoter complex is an excellent example of putting all the strategies discussed together by engineering proteins to obtain 3.0 Å resolution crystals and then using multiwavelength anomalous diffraction effects (MAD phasing) to solve the structure. To get good crystals it was necessary to use a deletion variant (residues 95-209) of the large subunit of TFIIA, a full-length small subunit of TFIIA, the 185-residue carboxy-terminal core of TATA-box binding protein (TBP), and an 18 base-pair fragment of the CYC1 promoter. The structure was solved using selenomethionine-substituted TBP and TFIIA, and a 5-bromine substituted oligonucleotide. Synchrotron data were collected at five wavelengths to exploit the two different anomalous scatterers.
16. Tan S, Hunziker Y, Sargent DF, Richmond TJ: Crystal structure of a yeast TFIIA/TBP/DNA complex Nature 1996, 381:127-151. This structure of the promoter complex used separate amino- and carboxy-terminal fragments of TFIIA, a full-length small subunit, the carboxy-terminal core of TATA-binding protein (TBP; residues 61-240) and a 16 base pair CYC1 promoter TATA-box-containing DNA fragment to obtain 2.0 Å resolution crystals. The structure was solved by standard molecular isomorphous replacement (MIR) methods to 2.5 Å.
17. Tong L, Qian C, Massariol M, Bonneau PR, Cordingley MG, Lagac L: A new serine-protease fold revealed by the crystal structure of human cytomegalovirus protease. Nature 1997, 383:272-275.
18. Qiu X, Culp JS, DiLella AG, Hellmig B, Hoog SS, Janson CA, Smith WW, Abdel-Meguid SS: Unique fold and active site in cytomegalovirus protease. Nature 1997, 383:275-279.
19. Shieh H-S, Kurumbail RG, Stevens AM, Stegeman RA, Sturman EK, Pak JY, Wittwer AJ, Palmier MO, Wiegand RC, Holwerda BC, Stallings WC: Three-dimensional structure of human cytomegalovirus protease. Nature 1997, 383:279-282.
20. Cho Y, Gorina S, Jeffrey PD, Pavletich NP: Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 1994, 265:346-355.
21. Jeffrey PD, Gorina S, Pavletich NP: Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 Angstroms. Science 1995, 267:1498-1502.
22. Kussie PH, Gorina S, Marechal V, Elenbaas B, Moreau J, Levine AJ, Pavletich NP: Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science 1996, 274:948-953.
23. Chayen NE, Boggon TJ, Cassetta A, Deacon A, Gleichmann T, Habash J, Harrop SJ, Helliwell JR, Nieh YP, Peterson MR et al.: Trends and challenges in experimental macromolecular crystallography. Q Rev Biophys 1996, 29:227-278. Excellent and very extensive review on macromolecular crystallography.
24. Helliwell JR: Macromolecular crystallography with synchrotron radiation. Cambridge, UK: Cambridge University Press; 1992.
25. Walter RL, Thiel DJ, Barne SL, Tate MW, Wall ME, Eikenberry EF, Gruner SM, Ealick SE: High resolution structure determination using CCD detectors and synchrotron radiation. Structure 1995, 3:835-844.
26. Munshi S, Lilyas L, Cavarelli J, Bomer W, McKinney B, Reddy V, Johnson JE: The 2.8 Å structure of a T=4 animal virus and its implications for membrane translocation of RNA. J Mol Biol 1996, 261:1-10.
27. Deacon A, Habash J, Harrop SJ, Helliwell JR, Hunter WN, Leonard GA, Peterson M, Haedener A, Kalb(Gilboa) AJ, Allinson NM et al.: SR instrumentation for optimized anomalous scattering and high resolution structure studies of proteins and nucleic acids. Rev Sci Instrum 1995, 66:1287-1292.
28. Genick VR, Bougstahl GE, Ng K, Ren Z, Pravervand C, Burke PM, Smager V, Teng TY, Schildkamp W, McRec DE et al.: Structure of a protein photocycle intermediate by millisecond time-resolved crystallography. Science 1997, 275:1471-1475.
29. Scott WG, Murray JB, Arnold JRP, Stoddard BL, Klug A: Capturing the structure of a catalytic RNA intermediate: The hammerhead ribozyme. Science 1996, 274:2065-2069.
30. Hall G: Silicon fixed detectors for X-ray diffraction studies with synchrotron radiation. Q Rev Biophys 1995, 28:1-32.
31. Young AC, Dewan JC, Nave CS, Tilton RF: Comparison of radiation-induced decay and structure refinement from X-ray data collected from lysozyme crystals at low and ambient temperature, J Appl Crystallogr 1993, 26:309-319.
32. Rodgers D: Cryocrystallography. Structure 1994, 2:1135-1140.
33. Teng TY: Mounting of crystals for macromolecular crystallography in a free-standing thin film. J Appl Crystallogr 1990, 23:387-391.
34. Mitchell EP, Garman EF: Flash freezing of protein crystals: investigation of mosaic spread and diffraction limit with variation of cryoprotectant concentration. J Appl Crystallogr 1994, 27:1070-1076.
35. Turkenberg JP, Dodson EJ: Modern developments in molecular replacement Curr Opin Struct Biol 1996, 6:604-610.
36. Rossmann MG: The molecular replacement method. Acta Crystallogr A 1990, 46:73-82.
37. Tong L, Rossmann MG: Rotation function calculations with GLRF. Methods Enzymol 1997, 276:594-611.
38. Urzhumtsev A, Podjarny AD: On the solution of the molecular replacement problem at very low resolution-application to large complexes. Acta Crystallogr D 1995, 51:888-895.
39. DeLano WL, Brunger AT: The direct rotation function: rotational patterson correlation search applied to molecular replacement Acta Crystallogr D 1995, 51:790-798.
40. Read RJ: As MAD as can be. Structure 1996, 4:11-16.
41. Pappa SH, Stewart AE, McDonald NQ: Incorporating anomalous scattering centres into macromolecules. Curr Opin Struct Biol 1996, 6:611-616.
42. Hendrickson WA: Determination of macromolecular structures from anomalous diffraction of synchrotron radiation. Science 1991, 254:51-58.
43. Burling FT, Weis WI, Flaherty KM, Bringer AT: Direct observation of protein solvation and discrete disorder using experimental cristallographic phases. Science 1996, 271:72-77. The work described in this paper probably represents the most accurate experimental phase determination in protein crystallography. Because of the accuracy of the resulting electron density, a particularly meaningful analysis of the solvent molecules as well as multiple sidechain conformations in the crystal structure could be made.